Literature DB >> 8664543

C/EBP alpha: a critical regulator of genes governing integrative metabolic processes.

G J Darlington1, N Wang, R W Hanson.   

Abstract

The role of C/EBPalpha in the developmental expression of a subset of genes governing essential metabolic processes has recently been elucidated using a mutant mouse model that lacks this transcription factor. The mutation results in a failure of the liver and white and brown adipose tissue to develop normal metabolic functions in the immediate perinatal period, including hepatic glycogen synthesis and gluconeogenesis and the synthesis and deposition of triglyceride in adipose tissue. The metabolic alterations are very similar to those of human infants born prior to the third trimester and suggest that many of the medical complications of prematurity are a result of the lack of activation of C/EBPalpha in development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8664543     DOI: 10.1016/0959-437x(95)80024-7

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  37 in total

1.  Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic.

Authors:  Danielle N Gross; Stephen R Farmer; Paul F Pilch
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

2.  C/EBP alpha and C/EBP beta regulate haptoglobin gene expression during rat liver development and the acute-phase response.

Authors:  Svetlana Dinić; Desanka Bogojević; Miodrag Petrović; Goran Poznanović; Svetlana Ivanovic-Matić; Mirjana Mihailović
Journal:  Mol Biol Rep       Date:  2005-09       Impact factor: 2.316

3.  Monitoring dynamic protein interactions with photoquenching FRET.

Authors:  Ignacio A Demarco; Ammasi Periasamy; Cynthia F Booker; Richard N Day
Journal:  Nat Methods       Date:  2006-07       Impact factor: 28.547

Review 4.  11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.

Authors:  Karen E Chapman; Jonathan R Seckl
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

5.  Wnt/beta-catenin signaling in hepatic organogenesis.

Authors:  Kari Nejak-Bowen; Satdarshan Ps Monga
Journal:  Organogenesis       Date:  2008-04       Impact factor: 2.500

6.  Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma.

Authors:  P De Vos; A M Lefebvre; S G Miller; M Guerre-Millo; K Wong; R Saladin; L G Hamann; B Staels; M R Briggs; J Auwerx
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 7.  Wnt/β-Catenin Signaling in Liver Development, Homeostasis, and Pathobiology.

Authors:  Jacquelyn O Russell; Satdarshan P Monga
Journal:  Annu Rev Pathol       Date:  2017-11-10       Impact factor: 23.472

8.  From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus.

Authors:  Kiran Musunuru; Alanna Strong; Maria Frank-Kamenetsky; Noemi E Lee; Tim Ahfeldt; Katherine V Sachs; Xiaoyu Li; Hui Li; Nicolas Kuperwasser; Vera M Ruda; James P Pirruccello; Brian Muchmore; Ludmila Prokunina-Olsson; Jennifer L Hall; Eric E Schadt; Carlos R Morales; Sissel Lund-Katz; Michael C Phillips; Jamie Wong; William Cantley; Timothy Racie; Kenechi G Ejebe; Marju Orho-Melander; Olle Melander; Victor Koteliansky; Kevin Fitzgerald; Ronald M Krauss; Chad A Cowan; Sekar Kathiresan; Daniel J Rader
Journal:  Nature       Date:  2010-08-05       Impact factor: 49.962

9.  AtbZIP34 is required for Arabidopsis pollen wall patterning and the control of several metabolic pathways in developing pollen.

Authors:  Antónia Gibalová; David Renák; Katarzyna Matczuk; Nikoleta Dupl'áková; David Cháb; David Twell; David Honys
Journal:  Plant Mol Biol       Date:  2009-05-18       Impact factor: 4.076

10.  Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0.

Authors:  M Orho; N U Bosshard; N R Buist; R Gitzelmann; A Aynsley-Green; P Blümel; M C Gannon; F Q Nuttall; L C Groop
Journal:  J Clin Invest       Date:  1998-08-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.